Endo International
-
Malvern-Based Endo Approves $3.5M in Retention Bonuses for Executives Ahead of Merger
Malvern-based Endo has approved $3.5 million in retention bonuses for its key executives as it works toward a merger with global specialty pharmaceutical firm Mallinckrodt,…
-
Malvern’s Endo Enters Into Agreement to Merge with Mallinckrodt in $6 Billion Deal
Malvern-based Endo has agreed to merge with Mallinckrodt in a cash and stock deal, valuing the combined pharmaceutical company at $6.7 billion, writes John George…
-
Malvern-Based Endo Hit with Court-Ordered Penalty for False Marketing
Malvern-based Endo Health Solutions has been ordered to pay over $1.5 billion in criminal financial penalties after the company admitted to falsely marketing Opana ER,…
-
As Malvern’s Endo Emerges from Bankruptcy, It Focuses on Growing Branded Pharmaceuticals Segment
Endo Inc., formed as a result of Malvern-based Endo International’s bankruptcy reorganization plan, has finalized the acquisition of most of the assets of its predecessor,…
-
Court Approves Malvern-based Endo International’s Reorganization Plan to Wipe Its Debt
Malvern-based Endo International received court approval earlier this week for its reorganization plan, over 18 months after the company filed for Chapter 11 bankruptcy protection,…
-
Endo International in Malvern to Pay $465M in Opioid Settlement
Malvern-based Endo International has agreed to pay up to $465 million over several years to settle federal civil and criminal charges over its marketing and…
-
Malvern’s Endo International Reaches Deal to Prepare to Emerge from Bankruptcy
Endo International, the Ireland-based biopharmaceutical company with U.S. headquarters in Malvern, is on track to finally emerge from bankruptcy after reaching a deal with the…
-
Malvern’s Endo International Up for Bankruptcy Auction This Summer
Malvern-based Endo International is officially up for bidding. A U.S. Bankruptcy Court has approved the auction, and bidding procedures can begin at $6 billion, writes…
-
Lawyers, Federal Regulators Critical of Malvern-Based Endo’s Royalties from Drug Opana
Lawyers and federal agencies are arguing that Malvern-based drug maker Endo is still profiting from the disgraced oxymorphone pill also known as Opana ER. Back in…
-
Malvern-Based Vanguard Still Committed to ‘Hybrid Working Model’ Despite Additional Office Building
Malvern-based Vanguard Group has expanded its office space in the Philadelphia area with the purchase of a nine-year-old high-end office complex close to its headquarters,…
-
Judge Approves Malvern-Based Endo’s $93,000 Incentives, Employee Bonuses Stalled
Malvern opioid maker Endo International has the greenlight to pay $93,000 in incentives to employees and sales reps, writes Bob Fernandez for The Philadelphia Inquirer.…
-
State Attorney Generals Object to Bonuses Paid to Malvern’s Endo Executives Before Bankruptcy
Seven state attorneys general, including Pennsylvania AG Josh Shapiro, and a federal bankruptcy overseer appointed by the court, are objecting to the $94 million paid…
-
Struggling with Opioid Litigation Settlements, Malvern-based Endo International Files for Bankruptcy
After struggling with the debt incurred due to opioid litigation settlements, Endo International, the Ireland-based pharmaceutical company with U.S. headquarters in Malvern, has filed for…
-
Malvern-based Endo International Likely to File for Chapter 11 Bankruptcy Protection
Endo International, the pharmaceutical giant based in Dublin, Ireland, with U.S. headquarters in Malvern, is expected to file for Chapter 11 bankruptcy protection, a move…
-
Latest Move Fuels Speculation That Pharmaceutical Giant in Malvern May Soon File for Bankruptcy
Endo International, the Dublin-based pharmaceutical company with its U.S. headquarters in Malvern, recently disclosed in a filing with the SEC that it will not be…
-
Malvern-Based Endo Creates Unique Campaign to Market Its Cellulite Treatment
Endo International, which has its U.S. headquarters in Malvern, has decided on a unique tagline for its latest marketing program for cellulite treatment Qwo: “Butt…
-
Malvern-Based Endo’s Stock Soars After Reaching $50 Million Settlement to Resolve Three Cases in New York
Endo International, the Dublin-based pharmaceutical company with U.S. headquarters in Malvern, reached a $50 million settlement to resolve three opioid cases in New York, writes…
-
Wall Street Journal: Swamped by Thousands of Opioid-Related Lawsuits, Malvern’s Endo Hires Restructurer
Endo International — based in Dublin, Ireland, with a U.S. headquarters in Malvern — has hired a financial restructuring firm to navigate its current legal…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
